Showing results (871-880 of 31,337) with videos related to
Sort By:
Pageof 3,134
Journal of Medicinal Chemistry|March 1, 1991
Biologically active taxol analogues with deleted A-ring side chain substituents and variable C-2' configurationsC S Swindell, N E Krauss, S B Horwitz, et al.Journal of Medicinal Chemistry|May 26, 2006
Synthesis and study of alendronate derivatives as potential prodrugs of alendronate sodium for the treatment of low bone density and osteoporosisPetr Vachal, Jeffrey J Hale, Zhe Lu, et al.Journal of Medicinal Chemistry|May 26, 2006
Novel peptidomimetic cysteine protease inhibitors as potential antimalarial agentsNicola Micale, Alan P Kozikowski, Roberta Ettari, et al.Journal of Medicinal Chemistry|May 26, 2006
Novel bis(1H-indol-2-yl)methanones as potent inhibitors of FLT3 and platelet-derived growth factor receptor tyrosine kinaseSiavosh Mahboobi, Andrea Uecker, Andreas Sellmer, et al.Journal of Medicinal Chemistry|May 26, 2006
Novel combretastatin analogues endowed with antitumor activityDaniele Simoni, Romeo Romagnoli, Riccardo Baruchello, et al.Journal of Medicinal Chemistry|May 26, 2006
New ligands with affinity for the alpha4beta2 subtype of nicotinic acetylcholine receptors. Synthesis, receptor binding, and 3D-QSAR modelingKarine Audouze, Elsebet Østergaard Nielsen, Gunnar M Olsen, et al.Journal of Medicinal Chemistry|May 26, 2006
Design, molecular modeling, synthesis, and anti-HIV-1 activity of new indolyl aryl sulfones. Novel derivatives of the indole-2-carboxamideRino Ragno, Antonio Coluccia, Giuseppe La Regina, et al.Journal of Medicinal Chemistry|May 26, 2006
Synthesis, biological activity, and DNA-damage profile of platinum-threading intercalator conjugates designed to target adenineRajsekhar Guddneppanavar, Gilda Saluta, Gregory L Kucera, et al.Journal of Medicinal Chemistry|May 26, 2006
Activity of B-nor analogues of neurosteroids on the GABA(A) receptor in primary neuronal culturesCristina Suñol, Daniel A García, Jordi Bujons, et al.Journal of Medicinal Chemistry|May 26, 2006
Bis(allixinato)oxovanadium(IV) complex is a potent antidiabetic agent: studies on structure-activity relationship for a series of hydroxypyrone-vanadium complexesYusuke Adachi, Jiro Yoshida, Yukihiro Kodera, et al.Pageof 3,134